主动呼吸控制对左侧乳腺癌改良根治术后放疗内乳淋巴结覆盖及正常组织受量的影响
本研究评估主动呼吸控制(ABC)技术对左侧乳腺癌改良根治术后放疗(PMRT)中包含内乳淋巴结(IMN)覆盖及危及器官受量的影响,并分析体重指数(BMI)与剂量学参数的关系。结果显示ABC较FB降低IMN覆盖率(94.5% vs 98%,P<.001),但仍满足覆盖标准(V90>90%),且显著降低心脏、左前降支、同侧肺V20及平均肺剂量(P<.001),对侧肺及对侧乳腺剂量无差异,BMI与任何剂量学参数无相关性。
要点
- ABC降低IMN覆盖率但仍满足V90>90%的剂量学标准
- ABC显著降低心脏、左前降支及同侧肺剂量
- BMI与ABC或FB计划的剂量学参数均无相关性
核心结论
- ABC降低左侧PMRT患者IMN覆盖率,但仍满足剂量学标准,可能无临床意义。
- ABC较FB显著保护危及器官,且不受BMI影响。
- 结果支持在需区域淋巴结照射(含IMN)的左侧PMRT患者中使用ABC。
研究设计与样本
- 患者均接受FB和ABC-Elekta CT模拟扫描,直接比较同一患者的ABC与FB计划。
- 分析BMI与记录的剂量学参数的相关性。
主要发现
- IMN PTV覆盖满足V90>90%标准,但ABC较FB降低(94.5% vs 98%,P<.001)。
- ABC显著降低所有测量的心脏和左前降支参数、同侧肺V20及平均肺剂量(P<.001)。
- 对侧肺和对侧乳腺剂量在ABC与FB计划间无差异。
- BMI与ABC或FB计划的任何剂量学参数均无相关性。
关键数值与推荐
- IMN PTV覆盖标准为接受超过90%处方剂量的体积(V90)>90%。
- ABC计划IMN V90为94.5%,FB计划为98%(P<.001)。
临床怎么用
- 对于需区域淋巴结照射(含IMN)的左侧PMRT患者,可考虑使用ABC以保护心脏和同侧肺。
- ABC下IMN覆盖率虽略降但仍达标,临床可接受。
- BMI不影响ABC的剂量学获益,肥胖患者也可应用。
局限性
- 需进一步前瞻性临床研究确定这些结果对晚期正常组织效应的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to evaluate the impact of the active breathing control (ABC) technique on IMN coverage and organs at risk in patients planned for postmastectomy radiation therapy (PMRT), with the inclusion of the internal mammary lymph nodes (IMNs). The effect of body mass index (BMI) on recorded dosimetric parameters was examined in the same patient cohort. METHODS AND MATERIALS: Fifty left-sided postmastectomy patients with breast cancer who underwent free-breathing (FB) and ABC-Elekta CT simulation scans were selected at random from an institutional breast cancer database between 2008 and 2014. The ABC plans were directly compared with FB plans from the same patient. RESULTS: The IMN planning target volume coverage met dosimetric criteria for coverage of receiving more than 90% of the prescribed dose (V90) >90%, although it decreased with ABC compared with FB (94.5% vs 98%, P < .001). Overall, ABC significantly reduced doses to all measured heart and left anterior descending coronary artery parameters, ipsilateral lung V20, and mean lung dose compared with FB (P < .001). There was no difference seen between the ABC and FB plans with respect to the dose to contralateral lung or contralateral breast. There was no correlation identified between BMI and any of the dosimetric parameters recorded from the ABC and FB plans. CONCLUSIONS: Our results suggest that ABC reduces IMN coverage in left-sided breast cancer patients planned for PMRT; however, dosimetric criteria for IMN coverage were still met, suggesting that this is not likely to be clinically significant. ABC led to significant sparing of organs at risk compared with FB conditions and was not affected by BMI. Collectively, the results support the use of ABC for breast cancer patients undergoing left-sided PMRT requiring regional nodal irradiation that includes the IMNs. Further prospective clinical studies are required to determine the impact of these results on late normal tissue effects.
引用
- Barry A, Rock K, Sole C, et al. The impact of active breathing control on internal mammary lymph node coverage and normal tissue exposure in breast cancer patients planned for left-sided postmastectomy radiation therapy. Pract Radiat Oncol. 2016. PMID: 28139424. doi:10.1016/j.prro.2016.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。